Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Procter & Gamble Company (PG), Colgate-Palmolive Company (CL): The Fed Waiting Game Has the Dow Down This Morning

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case they’re material to our investing thesis.

On days when the Federal Reserve announces major decisions, stock market participants often sit on their hands and wait to see what news comes in the afternoon. That largely seems to be the case today, as the Dow Jones Industrials are down 39 points as of 10:50 a.m. EDT, reflecting the overall market’s lack of enthusiasm. After a substantial rally over the past week and a half, short-term traders will be interested to see whether their predictions about the fate of Fed bond-buying prove correct. For long-term investors, though, the reality is that companies will eventually have to learn to live with a more normal interest-rate environment, and whether that adjustment begins now or in the future won’t make a huge difference to the long-term value of their stocks. In that light, investors should be hoping for the Fed to disappoint the market so they can buy the stocks they want at bargain prices.

The Procter & Gamble Company (NYSE:PG)

Among stocks leading the Dow lower is The Procter & Gamble Company (NYSE:PG), which is down 1.5%. The company was downgraded by analyst firm Barclays, which argued that The Procter & Gamble Company (NYSE:PG) hasn’t demonstrated an ability to produce the growth rates shareholders have enjoyed in the past. Some have argued that the entire consumer-goods sector has been overvalued lately, given investors’ appetite for defensively oriented stocks in a soaring stock market. Yet Barclays’ assessment was quite company-specific, as it rewarded rival Colgate-Palmolive Company (NYSE:CL) with an upgrade. Colgate’s recent success in boosting its market share against key competitors in important international markets has helped make the company a standout, threatening The Procter & Gamble Company (NYSE:PG)’s dominance.

Verizon Communications Inc. (NYSE:VZ) has fallen 1% as investors continue to assess the impact of the company’s huge borrowing spree last week. With the company taking out $49 billion in bonds as part of its buyout deal to take full control of Verizon Wireless, Verizon Communications Inc. (NYSE:VZ) will see a huge rise in interest expenses. The timing of the deal might prove perfect if the Fed’s move today sends rates soaring further, as most of Verizon’s new debt is long-term and allowed the company to lock in rates for years or even decades to come.

Finally, outside the Dow, shipping giant FedEx Corporation (NYSE:FDX) has jumped more than 3% after issuing a favorable earnings report. Improvements in operating profits and margins showed the company’s ability to make price increases stick, and FedEx reiterated its earnings guidance for the full year. More importantly, though, FedEx Corporation (NYSE:FDX)’s results stand as a measure of overall levels of economic activity, and its encouraging performance sheds a positive light on global economic growth potential in the near future.

The article The Fed Waiting Game Has the Dow Down This Morning originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends FedEx and Procter & Gamble. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!